16-47650549-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_000293.3(PHKB):c.1803G>A(p.Ala601Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000901 in 1,586,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000054 ( 0 hom. )
Consequence
PHKB
NM_000293.3 synonymous
NM_000293.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.914
Publications
0 publications found
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
- glycogen storage disease IXbInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 16-47650549-G-A is Benign according to our data. Variant chr16-47650549-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 257172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.914 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PHKB | NM_000293.3 | c.1803G>A | p.Ala601Ala | synonymous_variant | Exon 19 of 31 | ENST00000323584.10 | NP_000284.1 | |
| PHKB | NM_001363837.1 | c.1803G>A | p.Ala601Ala | synonymous_variant | Exon 19 of 31 | NP_001350766.1 | ||
| PHKB | NM_001031835.3 | c.1782G>A | p.Ala594Ala | synonymous_variant | Exon 20 of 32 | NP_001027005.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152070Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
66
AN:
152070
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000167 AC: 42AN: 251170 AF XY: 0.000103 show subpopulations
GnomAD2 exomes
AF:
AC:
42
AN:
251170
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000537 AC: 77AN: 1434204Hom.: 0 Cov.: 27 AF XY: 0.0000377 AC XY: 27AN XY: 715330 show subpopulations
GnomAD4 exome
AF:
AC:
77
AN:
1434204
Hom.:
Cov.:
27
AF XY:
AC XY:
27
AN XY:
715330
show subpopulations
African (AFR)
AF:
AC:
45
AN:
32946
American (AMR)
AF:
AC:
6
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25970
East Asian (EAS)
AF:
AC:
1
AN:
39564
South Asian (SAS)
AF:
AC:
1
AN:
85676
European-Finnish (FIN)
AF:
AC:
0
AN:
53214
Middle Eastern (MID)
AF:
AC:
1
AN:
5724
European-Non Finnish (NFE)
AF:
AC:
14
AN:
1086986
Other (OTH)
AF:
AC:
9
AN:
59436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000434 AC: 66AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000511 AC XY: 38AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
66
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
38
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
56
AN:
41514
American (AMR)
AF:
AC:
4
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5
AN:
68024
Other (OTH)
AF:
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disease IXb Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.